Background Randomised controlled trials (RCTs) have reported inconsistent effects from
intensified anticoagulation on clinical outcomes in Covid-19. We performed an aggregate …

Abstract Background Randomized controlled trials (RCTs) have reported inconsistent effects
from intensified anticoagulation on clinical outcomes in coronavirus disease 2019 (COVID …

Background The clinical impact of different prophylactic anticoagulation regimens among
hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear. We …

Background: COVID-19 patients are at high thrombotic risk. The safety and efficacy of
different anticoagulation regimens in COVID-19 patients remain unclear. Methods: We …

Background Anticoagulation in hospitalized COVID-19 patients has been associated with
survival benefit; however, the optimal anticoagulant strategy has not yet been defined. The …

Background Thromboembolism remains a detrimental complication of novel coronavirus
disease (COVID-19) despite the use of prophylactic doses of anticoagulation Objectives This …

Background Thrombotic complications are considered among the main extrapulmonary
manifestations of coronavirus disease 2019 (COVID-19). The optimal type and duration of …

Background Thrombosis may contribute to morbidity and mortality in Covid-19. We
hypothesized that therapeutic anticoagulation would improve outcomes in critically ill …

Objective We aimed to perform a meta-analysis to summarize the overall evidence from
randomized controlled trials related to higher-intensity anticoagulation in hospitalized …

Background COVID‐19 disease‐related coagulopathy and thromboembolic complication,
an important aspect of the disease pathophysiology, are frequent and associated with poor …